Skip to main content
SpringerLink
Log in

NICE recommends three treatments

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. see PharmacoEconomics & Outcomes News 663 p10; 803077379

References

  1. NICE. NICE gives green light to treatment for wet AMD in final guidance. Media Release : 24 Jul 2013. Available from: URL: http://www.nice.org.uk.

  2. NICE. NICE says yes to blood disorder treatment in final guidance. Media Release : 24 Jul 2013. Available from: URL: http://www.nice.org.uk.

  3. NICE. New treatment approved for adolescents with bipolar disorder. Internet Document : 29 Jul 2013. Available from: URL: http://www.nice.org.uk.

  4. NICE. NICE consults on belimumab for systemic lupus erythematosus. Media Release : 23 Jul 2013. Available from: URL: http://www.nice.org.uk.

  5. NICE. Views sought on draft NICE guidance that says breast cancer drug is not value for money. Media Release : 5 Aug 2013. Available from: URL: http://www.nice.org.uk.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE recommends three treatments. PharmacoEcon Outcomes News 684, 10 (2013). https://doi.org/10.1007/s40274-013-0619-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0619-8

Search

Navigation